Company / Shares Outstanding
Summit Therapeutics Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
747.7M
FY2025
5-year range
98.0M / 747.7M
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#16 of 212
Health Care
What the data says
Among 212 Health Care companies, Summit Therapeutics Inc. is in the bottom 8% for shares outstanding. Shares Outstanding has increased for 3 consecutive years, from 98039540.00 in FY2022 to 747702265.00 in FY2025.
Based on SEC 10-K filings.
747702265.00 in FY2025 with a 5-year CAGR of +61.9%. Top quartile in the Health Care sector.
Increased from 211091425.00 to 747702265.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +96.8%
- 5-Year CAGR
- +61.9%
- 10-Year CAGR
- -
Sector benchmark
+143.8% above sector average
Key checks
Key Insights
- Summit Therapeutics Inc.'s shares outstanding has grown for 3 consecutive years.
- In FY2025, shares outstanding increased 6.6% year-over-year.
- Ranks #16 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 747.7M | +6.6% |
| FY2024 | 701.7M | +232.4% |
| FY2023 | 211.1M | +115.3% |
| FY2022 | 98.0M | -70.8% |
| FY2021 | 336.2M | +400.4% |
| FY2020 | 67.2M | +104.6% |
| FY2019 | 32.8M | +90.5% |
| FY2018 | 17.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026